IMPORTANT NOTICE: At Fortis Healthcare, we are fully supportive of the National priorities set out by the Hon’ble Prime Minister of India. Further to the directives of the Government provided in their press release dated 8th Nov 2016, payments at Government hospitals can be made through 500 and 1000 Rupee denomination notes. In view of the hardship being caused to the large number of patients at private hospitals, we have made an urgent representation to the Government that this exemption should apply equally, for payments, at private hospitals. We are following up with the authorities and hope the Government will step in quickly to resolve this anomaly. Meanwhile, at Fortis hospitals across the country, we continue to accept payments through credit card, debit card and electronic banking transfers. As 500 and 1000 Rupee denomination notes are no longer legal tender we are only accepting 100 Rs and lower currency notes. As per Government regulation, a PAN card and legitimate ID proof is however required for payments in cash exceeding Rs 50,000. Meanwhile we continue to ensure that emergency cases get immediate medical attention without delay whatsoever and have put in more administrative staff and help desks to assist patients.

Doctor Profile

Dr. Ashit Syngle

Dr. Ashit Syngle, MD

21+ Years Of Experience

Consultant - Fortis Hospital, Mohali

Rheumatology

OPD Schedule - +91 172 469 2222, +91 172 502 1222

  • Tue

    09:00 AM - 11:00 AM

    04:00 PM - 05:00 PM

  • Thu

    09:00 AM - 11:00 AM

    04:00 PM - 05:00 PM


  • Request Appointment

Dr Ashit Syngle, a post-graduate in Internal Medicine from the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh (India). He has been a topper all through his distinguished academic career scoring distinctions in many subjects and was declared the “Best Graduate”. He has been maintaining his distinction too as a practicing Diabetologist and Rheumatologist since 1993. He has several prestigious national & international certifications to his credit. He is also an alumnus of Indian School of Business, Hyderabad. His talk shows on All India Radio and television have been very popular.
He was responsible for starting the first Rheumatology Clinic at Fortis Healthcare in 2003. His passion for work and compassion for patients has lead to excellence in his field, being counted among India’s leading rheumatologists and has also led to international recognition. He has also been providing expert medical opinion to Canada, New Zealand & Australian High Commissions on difficult cases through their DMPs for the last 19 years. He has designed and successfully carried out several path breaking interventional studies in the field of rheumatology & has contributed tremendously to health education in rheumatology. He is a great teacher. 10 postgraduate thesis from Faculty of Medicine, Dept. of Pharmaceutical Science, Punjabi University have been completed and submitted under his expert supervision and guidance. Two students from the same department are presently undergoing PhD dissertation on rheumatology topics under his supervision.
Designation: Consultant.
Department/Specialty: Rheumatology & Internal Medicine

Languages spoken: English, Hindi, Punjabi
Total Years’ of Experience: 21 years
Previous experience: 5 years
Medical Education, Certifications and fellowships: MD (Internal Medicine) PGI; FCCP,
Diab. (Univ. of New Castle, Australia)
ICH-GCP Certified
COP for Rheumatologists Ghent University Hospital, Ghent , Belgium
Educational Activity on Lupus Nephritis of the American Academy of Continuing Medical Education
European Society of Hypertension (ESH) Master’s Course on Hypertension.
Diabetes 2012: From Research to Clinical Practice, at Joslin Diabetes Center, Boston, MA, USA.
“Transformational Leadership Programme for Healthcare Management” at Indian School of Business, Hyderabad.
Professional Memberships:o Dr Ashit is a life member of Cardiological Society of India, Indian Rheumatology Association & Indian Medical Association. He is also a member of American College of Cardiology (ACC). He has been unanimously elected as the Joint Secretary and is an Executive Member of Academic Association of Physicians of Chandigarh. He has been a past member of American Diabetic Association (ADA).
Clinical Interests/ Specialised Treatments /Area of Expertise: Rheumatic Diseases: Rheumatoid Arthritis, Ankylosing Spondylitis, Gout, SLE (Lupus), Osteoporosis etc. Diabetes, Hypertension, Coronary Artery Disease (CAD), Cardio-Rheuma, Dyslipidaemias, Infectious Diseases
Awards & Honors: His recent International Recognitions include - Nomination to Marquis Who’s who in the World for 2011 edition by editors of this reputed international publication from USA. Work on Endothelial dysfunction in ankylosing spondylitis cited & featured by MDLinx.com - an international site which screens 1200 medical journals daily for outstanding work – on 22nd March, 2010. His Rheumatology research is continuously cited in ‘Top 10 Articles’ by BioMedLib and won the “Case of the Day Contest” at the 26th Annual Conference of Indian Rheumatology Association (IRACON 2010) at Bhubaneswar on 26th November, 2010. He has delivered many Public Talks and made several Presentations and has had the honor to chair several scientific sessions in India and abroad. He chaired the prestigious Ankylosing Spondylitis symposium during Osteocon 2007 at Dubai in August 2007. He has great passion for clinical research and has designed and conducted several path breaking clinical studies. His own clinical research on endothelial dysfunction in rheumatoid arthritis presented at the 13th Congress of the Asia Pacific League of Associations for Rheumatology (APLAR 2008) at Pacifico Yokohama, Japan on 25th Sept, 2008 & APLAR 2012 at Dead Sea, Amman, Jordan on 11th Sept, 2012 was very well received and much appreciated. Some of the Interventional Studies Designed by Dr Syngle include ‘Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor α blockade’, published in Clinical Rheumatology, Feb. 2010. He has actively participated in several national and international medical conferences, the most recent ones being the 60th Annual Scientific Session of American College of Cardiology (ACC) at New Orleans, USA April, 2011; EULAR 2011 London May, 2011; Annual Conference of American Diabetic Association at San Diago, USA June, 2011 & Annual Conference of American College of Rheumatology at Chicago, USA November, 2011; EULAR 2012 Berlin June 2012; 15th Congress of the Asia Pacific League of Associations for Rheumatology at Dead Sea Amman-Jordan September 10-14, 2012.
Research and Publications:
Editor of Rheumatology: Principles & Practice a multiauthor textbook with contributors from 3 continents (Europe, Australia & Asia) published by JP Brothers, Medical Publishers 2010.
Authorship in Books:
Contributed a chapter entitled “Clinical Perspective of the Present Status of Treatment for Major Age-related Diseases” in a book “Aging Interventions and Therapies”, published in May 2005, by the World Scientific Publishers, Singapore.
Contributed a chapter “Arthritis and its Treatment” for a book “Prevention and Treatment of Age Related Diseases” to be published in Oct., 2006 by Springer from Europe.
First author of “ Crystal-related Arthropathies” in Rheumatology: Principles & Practice a multiauthor textbook with contributors from 3 continents (Europe, Australia & Asia) published by JP Brothers Medical Publishers 2010.
Coauthor of “Lung Involvement in Rheumatic Diseases” in Rheumatology: Principles & Practice a multiauthor textbook with contributors from 3 continents (Europe, Australia & Asia) published by JP Brothers Medical Publishers 2010.
A chapter “Gout and Hyperuricemia” published in Rheumatology in Primary Care by KYA Foundation in 2012.
Research Papers:
"Systemic Sclerosis with Digital Gangrene" Published as Case of Quarter in Bulletin of Indian Rheumatism Association Vol.S; No.4,1991.
“Rheumatoid Arthritis with Skeletal Fluorosis” published as Case of Quarter in Bulletin of Indian Rheumatism Association Vol.6; No.1,1992.
"Clinical Efficacy and side effects of IDPH-8261 (A New Non-Steroidal Anti-Inflammatory Drug) as compared to Indomethacin in patients of Ostcoarthritis and Rheumatoid Arthritis. JIRA 1994, Vol. 2, No.4.
"Congenital Unilateral Pulmonary Hypoplasia" Bull. PGIMER, 30.1.1996.
“Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis”. Scand J Rheumatol 2009, 38: 1502-7732, Volume 38, Issue 1, 15-22.
“Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor α blockade” Clinical Rheumatology 2010;29;7; 763.
“Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis”
International Journal of Rheumatic Diseases Volume 15, Issue 1, pages 45–55, February, 2012.
“Effect of Spironolactone on inflammation and endothelial dysfunction in Rheumatoid Arthritis”. (Abstract) International Journal of Rheumatic Diseases Vol. 11, Sept., 2008.
Influence of TNF-alpha blockade on nitric oxide production in patients with Ankylosing Spondylitis: Correlation of serum nitrite level with clinical response and benefit. (Abstract) International Journal of Rheumatic Diseases Vol. 13, Supplement 1., 2010.
Advanced glycation end-products inhibitor, Vonder®, improves endothelial dysfunction in rheumatoid arthritis. (Vonder®: Benfotiamine50mg+Pyridoxamine 50mg+Methylcobalamin
500µg). (Abstract) International Journal of Rheumatic Diseases Vol. 13, Supplement 1., 2010.
Effect of Spironolactone on Inflammation and Endothelial Dysfunction in Ankylosing Spondylitis. IJR Nov. 2010, Vo. 5, No. 3 (Suppl) Abstr P 38.
Determining the efficacy of Advanced Glycated End Products inhibitor, Vonder® on disease outcome in osteoarthritis patients. IJR Nov. 2010, Vo. 5, No. 3 (Suppl) Abstr P 42.
“IL-6 blockade improves endothelial dysfunction in Rheumatoid Arthritis” IJR Nov. 2011, Vo. 6, No. 3 (Suppl) Abstr P S8-S9.
“Nitric Oxide as a biomarker of disease activity and therapeutic response in rheumatoid arthritis and ankylosing spondylitis” IJRD Sept 2012, Vol 15, Suppl 1 Abstr P 44.
“Autonomic Neuropathy in Rheumatoid Arthritis & Ankylosing Spondylitis: Peripheral Sympathetic and Cardiovascular Autonomic Function Assessment” IJRD Sept 2012, Vol 15, Suppl 1 Abstr P86.
Several articles on health topics of public interest have appeared in the press and on the web.
Medical Breakthroughs/ Interesting Case Studies: Work on Endothelial dysfunction in ankylosing spondylitis cited & featured by MDLinx.com - an international site which screens 1200 medical journals daily for outstanding work – on 22nd March, 2010.
“Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis”. Scand J Rheumatol 2009, 38: 1502-7732, Volume 38, Issue 1, 15-22.
“Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis”
International Journal of Rheumatic Diseases Volume 15, Issue 1, pages 45–55, February, 2012.
Published Rheumatology research continuously cited in ‘Top10 Articles’ by BioMedLib.